Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Markovitz

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|August 30, 2024
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansionMeng Yu, Ang Lin, Faezzah Baharom, et al.
Genes & Development|April 5, 2011
The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrityFerdinand Kappes, Tanja Waldmann, Veena Mathew, et al.
Antiviral Research|April 20, 2011
Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs)Geoffrey Férir, Kurt Vermeire, Dana Huskens, et al.
Cancer Research|August 15, 2009
Melanoma proliferation and chemoresistance controlled by the DEK oncogeneMichael S Khodadoust, Monique Verhaegen, Ferdinand Kappes, et al.
Arthritis and Rheumatism|February 1, 2011
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigenNirit Mor-Vaknin, Ferdinand Kappes, Amalie E Dick, et al.
Nature Chemical Biology|June 28, 2011
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleAndrew C Stelzer, Aaron T Frank, Jeremy D Kratz, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancerSusana M Chan, Zoe Raglow, Anupama Pal, et al.
Journal of Virology|May 1, 2015
Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related SequencesRafael Contreras-Galindo, Mark H Kaplan, Derek Dube, et al.
Journal for Immunotherapy of Cancer|January 18, 2023
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stromaMary K McKenna, Ada Ozcan, Daniel Brenner, et al.
Plos One|September 23, 2016
Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain BarrierSheng-He Huang, Feng Chi, Liang Peng, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|August 30, 2024
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansionMeng Yu, Ang Lin, Faezzah Baharom, et al.
Genes & Development|April 5, 2011
The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrityFerdinand Kappes, Tanja Waldmann, Veena Mathew, et al.
Antiviral Research|April 20, 2011
Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs)Geoffrey Férir, Kurt Vermeire, Dana Huskens, et al.
Cancer Research|August 15, 2009
Melanoma proliferation and chemoresistance controlled by the DEK oncogeneMichael S Khodadoust, Monique Verhaegen, Ferdinand Kappes, et al.
Arthritis and Rheumatism|February 1, 2011
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigenNirit Mor-Vaknin, Ferdinand Kappes, Amalie E Dick, et al.
Nature Chemical Biology|June 28, 2011
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleAndrew C Stelzer, Aaron T Frank, Jeremy D Kratz, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancerSusana M Chan, Zoe Raglow, Anupama Pal, et al.
Journal of Virology|May 1, 2015
Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related SequencesRafael Contreras-Galindo, Mark H Kaplan, Derek Dube, et al.
Journal for Immunotherapy of Cancer|January 18, 2023
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stromaMary K McKenna, Ada Ozcan, Daniel Brenner, et al.
Plos One|September 23, 2016
Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain BarrierSheng-He Huang, Feng Chi, Liang Peng, et al.
Pageof 8